» Articles » PMID: 30787976

RNA-Seq Profiling of Circular RNAs and Potential Function of Hsa_circ_0002360 in Human Lung Adenocarcinom

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2019 Feb 22
PMID 30787976
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

CircRNAs have been identified play a key role in various different types of cancer. However, their role in lung adenocarcinoma remains unclear. In this study, we explored the specific circular transcriptome and characterized the circRNA expression profiles of five paired lung adenocarcinoma (LAC) tissues relative to adjacent normal tissues from LAC patients using next-generation sequencing (NGS). To illuminate circRNAs function, their gene targets were initially predicted before using, Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses to further analyse the associated significant cell signalling pathways and functions. The potential interactions between circRNA-miRNA-mRNA were also investigated. Additionally, qRT-PCR assay, Western blot and Immunohistochemistry were performed to validate the differential expression of circRNA, microRNA and mRNA in the LAC group in comparison to the control group. Two-hundred-eighty-five dysregulated circular transcripts were found in LAC tissues, among which 102 and 183 were either up or down regulated, respectively. Our biological analysis suggested that the host genes of differentially expressed circRNAs targeted to cancer-related processes and mechanisms. The interaction maps of the circRNA-miRNA-target gene were constructed using Cytoscope. In further study, hsa_circ_0002360 was found to be the most significantly overexpressed circRNA in LAC tissues by interacting with miRNA and its corresponding mRNA. Our results showed that hsa_circ_0002360 was aberrantly and abundantly expressed and implicated in the development of LAC, suggesting a valuable therapeutic target for LAC treatment.

Citing Articles

Has_circ_0002360 promotes the progression of lung adenocarcinoma by activating miR-762 and regulating PODXL expression.

Yan Y, Zhang Y, He Y, Bu X Transl Cancer Res. 2024; 13(8):4172-4186.

PMID: 39262484 PMC: 11384312. DOI: 10.21037/tcr-24-279.


Circular RNAs in lung cancer: implications for preventing therapeutic resistance.

Liu W, Sun Y, Huo Y, Zhang L, Zhang N, Yang M EBioMedicine. 2024; 107:105309.

PMID: 39191172 PMC: 11445705. DOI: 10.1016/j.ebiom.2024.105309.


Identification of Circular RNAs as Biomarker Candidates in Lung Cancer Treatment.

Apaydin B, Mert U, Asadi M, Muftuoglu C, Caner A Asian Pac J Cancer Prev. 2024; 25(6):2147-2157.

PMID: 38918678 PMC: 11382869. DOI: 10.31557/APJCP.2024.25.6.2147.


CircRUNX1 drives the malignant phenotypes of lung adenocarcinoma through mediating the miR-5195-3p/HMGB3 network.

Wang Y, Li H, Chen W, Huang X, Fan R, Xu M Gen Thorac Cardiovasc Surg. 2023; 72(3):164-175.

PMID: 37474742 DOI: 10.1007/s11748-023-01960-5.


Curcumin suppresses lung cancer progression via circRUNX1 mediated miR-760/RAB3D axis.

Wu X, Chen H, Liu N, Liu S, Lin G Thorac Cancer. 2022; 14(5):506-516.

PMID: 36523170 PMC: 9925347. DOI: 10.1111/1759-7714.14773.


References
1.
Sanger H, KLOTZ G, Riesner D, Gross H, KLEINSCHMIDT A . Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976; 73(11):3852-6. PMC: 431239. DOI: 10.1073/pnas.73.11.3852. View

2.
Goto S, Okuno Y, Hattori M, Nishioka T, Kanehisa M . LIGAND: database of chemical compounds and reactions in biological pathways. Nucleic Acids Res. 2001; 30(1):402-4. PMC: 99090. DOI: 10.1093/nar/30.1.402. View

3.
Dennis Jr G, Sherman B, Hosack D, Yang J, Gao W, Lane H . DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003; 4(5):P3. View

4.
Wang S, Robertson G, Zhu J . A novel human homologue of Drosophila polycomblike gene is up-regulated in multiple cancers. Gene. 2004; 343(1):69-78. DOI: 10.1016/j.gene.2004.09.006. View

5.
Bozcuk H, Artac M, Ozdogan M, Savas B . Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials. Cancer. 2005; 104(12):2650-7. DOI: 10.1002/cncr.21540. View